Log in to save to my catalogue

Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer

Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2622284618

Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer

About this item

Full title

Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer

Publisher

New York: Springer US

Journal title

Current oncology reports, 2022-01, Vol.24 (1), p.113-123

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose of Review
The use of single-agent or combination immunotherapy strategies has revolutionized the management of patients with non-small cell lung cancer (NSCLC). Here, we review the current role for CTLA-4 inhibitors in early-stage resectable NSCLC, unresectable stage III NSCLC, and in metastatic NSCLC.
Recent Findings
Immunotherapy...

Alternative Titles

Full title

Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2622284618

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2622284618

Other Identifiers

ISSN

1523-3790

E-ISSN

1534-6269

DOI

10.1007/s11912-021-01164-1

How to access this item